Skip to Main Content
An official website of the United States government
CDAS has a New Look: On December 9th, the CDAS website was updated with a new design! The update incorporates all of the existing CDAS functionality with a more modern and user friendly interface.

Lung Cancer Screening and Risk Assessment

Principal Investigator

Name
Edward Tan

Degrees
Bachelor of Science (Computer Science)

Institution
iota Medtech

Position Title
CTO

Email
edward.tan@iotamedtech.com

About this CDAS Project

Study
NLST (Learn more about this study)

Project ID
NLST-1008

Initial CDAS Request Approval
Jan 13, 2023

Title
Lung Cancer Screening and Risk Assessment

Summary
Globally, lung cancer is the leading cause of cancer-related death, especially among men. Detection of lung cancer on LDCT is a labor intensive and tedious task, as it requires detection of
small nodules in a large set of images. Hence the use of AI in the screening will significantly increase the screening process.
Iota medtech does research and development of AI solutions to solve healthcare related problems.
We are currently developing an AI model which will detect the presence of pulmonary nodules in LDCT and CT scans, and give a risk scoring base on the likelihood of malignant or benign. We now seek access to the NLST data to further our ongoing research and development work in our AI to detect lung cancer.

Aims

Development and testing of our AI model for pulmonary nodule detection and give a risk scoring

Collaborators

Tan Jun Xian, iota medtech